Gutsy Generac Short Seller Gets Vindication – Albeit 118 Days Later As Shares Drop
In a short report on Generac Holdings Inc. (NYSE: GNRC) that was issued in June, Spruce Point Capital Management speculated the company might be
Barclays Downgrades FIGS: Here’s What You Need To Know
Barclays downgraded its rating of FIGS (NYSE:FIGS) to Equal-Weight with a price target of $9.00, changing its price target from $15.00 to $9.00.
Shares of FIGS are trading down 4.58% over the last 24 hours, at $7.80 per share.
Analyst Ratings for FIGS
Analysts have provided the following ratings for FIGS (NYSE:FIGS) within the last quarter:
‘Very Pleased To Issue A Unique New Forensic Report On Figs – A Maker Of Medical Scrubs Where We So No Competitive Advantages, And A Management Team Prone To Extreme Business And Financial Exaggeration. 45-60% Downside Risk’ – Spruce Point Capital
https://twitter.com/sprucepointcap/status/1567498349330288640
https://www.sprucepointcap.com/figs-inc/
Billionaire Ron Baron Is ‘Incredibly Bullish’ On Tesla, SpaceX And This Apparel Company He Calls ‘The Lululemon Of Healthcare’
There aren't many investors with a 20-year time horizon at the age of 79, but that's exactly how far billionaire investor Ron Baron is looking ahead, and it's safe to say he's optimistic about what's to come.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
FIGS Q2 EPS $0.03 Beats $0.02 Estimate, Sales $122.25M Beat $119.73M Estimate
FIGS (NYSE:FIGS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 50 percent. This is a 62.5 percent decrease over earnings of $0.08 per share from the same period last